Skip to Content

Logo (Actavis) 422 (Lamotrigine Extended-Release 100 mg)

Pill with imprint Logo (Actavis) 422 is Gray, Round and has been identified as Lamotrigine Extended-Release 100 mg. It is supplied by Actavis Pharma, Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; epilepsy (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 422

Lamotrigine extended-release 100 mg Logo (Actavis) 422 Front
Lamotrigine extended-release 100 mg Logo (Actavis) 422 Back

Lamotrigine Extended-Release

Imprint:
Logo (Actavis) 422
Strength:
100 mg
Color:
Gray
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00228-1422

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide